In women with obesity and food addiction, 8 weeks of beta-caryophyllene did not change oxytocin levels compared with placebo.
In plain wordsIn women with obesity and food addiction, beta-caryophyllene did not change the body's own oxytocin levels compared with placebo.
- Peptide
- Oxytocin
- Outcome
- No significant changeOxytocin level
- Study
n = 52
- Comparator
- Placebo
- Outcome group
- Endogenous peptide levels · Endocrine and hormones
Source sentences
β-caryophyllene supplementation had no significant effect on body composition, anthropometric indices, appetite, eating behavior, dietary intake, physical activity level, mental health, and levels of oxytocin and neuropeptide Y (NPY), compared to the placebo.
1 context sentence(design, population, supporting numbers)
Women with obesity and FA, diagnosed by the Yale Food Addiction Scale Score (YFAS-S) ≥3, were randomly allocated to receive a β-caryophyllene softgel (n = 26) (100 mg/daily with meal) or placebo (n = 26) for 8 weeks.
This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.